⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SpotitEarly and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SpotitEarly
↗New Jersey, USA
SpotitEarly is a health-tech company that has developed a proprietary Bio-AI Hybrid platform, known as LUCID, for non-invasive, multi-cancer early detection. The technology utilizes scent-based bio-detectors combined with artificial intelligence to identify cancer-associated signals in breath samples, aiming to provide an accessible and affordable screening solution for breast, colorectal, lung, and prostate cancers.
Since entering the U.S. market in May 2025, the company has focused on building a robust clinical evidence base through partnerships with major health systems, such as Hackensack Meridian Health, and research institutions like Fox Chase Cancer Center. The company was recognized as a 'Fierce 15' company in 2026 for its innovative approach to addressing barriers in early cancer screening.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$26.5M
Investors:Aleph VC, Boost Capital Partners, Hanaco Ventures, sequel, StageOne Ventures, Torch Capital, Abrahami Avishai, Itzik Ben-Bassat
PIPELINE
Stage:Commercial
Lead Drug Stage:Early detection screening test (Commercial/Clinical)
Modalities:Diagnostics
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Hackensack Meridian Health (PINK Study for breast cancer), Fox Chase Cancer Center (Lung cancer research collaboration)
COMPETITION
Position:Emerging
Competitors:Exact Sciences, Harbinger Health
LEADERSHIP
Key Executives:
Shlomi Madar - CEO
LINKS
Website:spotitearly.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SpotitEarly. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.